L. Phillips

发表

Clinical guidelines and off‐license recombinant activated factor VII: content, use, and association with patient outcomes

C. Willis, P. Cameron, L. Phillips, 2009, Journal of thrombosis and haemostasis : JTH.

The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII.

J. McNeil, J. Isbister, Z. McQuilten, 2015, Blood transfusion = Trasfusione del sangue.

Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis.

P. Myles, Julian A. Smith, L. Phillips, 2009, British journal of anaesthesia.

Age of red blood cells and mortality in the critically ill

R. Bellomo, M. Bailey, E. Wood, 2011, Critical care.

Investigation of outcomes following recombinant activated FVII use for refractory bleeding during abdominal aortic aneurysm repair.

C. Willis, P. Cameron, L. Phillips, 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology

E. Wood, J. Isbister, N. Andrianopoulos, 2016, BMC Research Notes.

Introduction of universal prestorage leukodepletion of blood components, and outcomes in transfused cardiac surgery patients.

C. Reid, R. Bellomo, J. McNeil, 2015, The Journal of thoracic and cardiovascular surgery.

Variation in the use of recombinant activated factor VII in critical bleeding

C. Willis, P. Cameron, L. Phillips, 2009, Internal medicine journal.

The Safety of Recombinant Factor VIIa in Cardiac Surgery

B. Billah, P. Cameron, L. Phillips, 2010, Anaesthesia and intensive care.

Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes

C. Willis, P. Cameron, L. Phillips, 2010, Vox sanguinis.

Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports.

B. Leighton, L. Phillips, A. Zatta, 2011, Anesthesiology.

Recombinant Activated Factor VII in Obstetric Hemorrhage: Experiences from the Australian and New Zealand Haemostasis Registry

P. Cameron, L. Phillips, S. Gatt, 2009, Anesthesia and analgesia.

Hospital blood bank information systems accurately reflect patient transfusion: results of a validation study

E. Wood, Z. McQuilten, L. Phillips, 2011, Transfusion.

Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register

J. McNeil, P. Cameron, L. Phillips, 2008, Internal medicine journal.

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

A review on decision support for massive transfusion: understanding human factors to support the implementation of complex interventions in trauma

E. Wood, P. Cameron, S. Jeffcott, 2012, Transfusion.

Prospective comparison of point‐of‐care international normalised ratio measurement versus plasma international normalised ratio for acute traumatic coagulopathy

P. Cameron, G. O'Reilly, L. Phillips, 2012, Emergency medicine Australasia : EMA.

Transfusion practice varies widely in cardiac surgery: Results from a national registry.

C. Reid, J. McNeil, E. Wood, 2014, The Journal of thoracic and cardiovascular surgery.

Off-Label Use of Recombinant Factor VIIa in Pediatric Patients

Z. McQuilten, L. Phillips, A. Zatta, 2012, Pediatrics.

Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand

P. Cameron, L. Phillips, S. Dunkley, 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The Australasian haemostasis register for clinical use of recombinant activated factor VII

J. Isbister, P. Cameron, L. Phillips, 2007 .

The thrombotic thrombocytopenic purpura registry: a new national resource to inform patient care and medical research

J. McNeil, E. Wood, S. Opat, 2009, Internal medicine journal.

Antiﬁbrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis

L. Phillips, D. McIlroy, J. A. Smith, 2009 .

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.

R. Lindeman, P. Cameron, L. Phillips, 2008, The Annals of thoracic surgery.

Recombinant factor VIIa in trauma patients with the 'triad of death'.

M. Parr, P. Cameron, L. Phillips, 2012, Injury.

Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry

E. Wood, S. Cohney, Z. McQuilten, 2016, Internal medicine journal.

The use of recombinant activated factor VII in trauma patients: Experience from the Australian and New Zealand haemostasis registry.

M. Parr, Z. Balogh, A. Joseph, 2007, Injury.

Elucidating the clinical characteristics of patients captured using different definitions of massive transfusion

E. Wood, J. Isbister, Z. McQuilten, 2014, Vox sanguinis.

Use of Recombinant Factor VIIa in Patients with AmnioticFluid Embolism A Systematic

P. Cameron, D. Smit, B. Leighton, 2011 .

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding

J. Isbister, P. Cameron, L. Phillips, 2013, ANZ journal of surgery.

Identifying and improving unreliable items in registries through data auditing.

J. McNeil, D. Jolley, P. Cameron, 2011, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Contemporary management of neonatal alloimmune thrombocytopenia: good outcomes in the intravenous immunoglobulin era: results from the Australian neonatal alloimmune thrombocytopenia registry

E. Wood, H. Savoia, R. Holdsworth, 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Transfusion practice and guidelines in Australian and New Zealand intensive care units

R. Bellomo, E. Wood, V. Pettilä, 2010, Intensive Care Medicine.

Monitoring drug safety with registries: useful components of postmarketing pharmacovigilance systems.

J. McNeil, P. Cameron, C. Willis, 2012, Journal of clinical epidemiology.

Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology

E. Wood, J. Isbister, N. Andrianopoulos, 2016, BMC Research Notes.

Uncontrolled bleeding in surgical patients: the role of recombinant activated factor VIIa.

J. Isbister, L. Phillips, A. Zatta, 2009, Current drug targets.

Use of recombinant activated factor VII in the treatment of critical bleeding in burns patients: Haemostasis Registry case review

P. Cameron, C. Willis, L. Phillips, 2010 .

Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports.

B. Leighton, L. Phillips, A. Zatta, 2011, Anesthesiology.

Flow Chart for Amniotic Fluid Embolism Management A Tricky Tool

L. Phillips, 2012 .